Oromandibular dystonia: a serious side effect of capecitabine

BACKGROUND: Capecitabine has activity against several types of cancer. In 10-15% of patients treated with capecitabine, treatment is discontinued because of serious adverse reactions, mostly within the first weeks of treatment. CASE PRESENTATION: A 56 year-old female patient presented at the emergen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: van Pelt-Sprangers, Melanie JM, Geijteman, Eric CT, Alsma, Jelmer, Boere, Ingrid A, Mathijssen, Ron HJ, Schuit, Stephanie CE
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2015
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358849/
https://ncbi.nlm.nih.gov/pubmed/25850956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1132-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky